Africa Treatment Access: Contact President, Congress on Africa Executive Order.
We suspect that this news story was leaked in order to test the political strength of supporters of treatment access for Africa, vs. that of the pharmaceutical industry. Although this industry has given millions of dollars of campaign contributions, mostly to Republicans, no one knows how President Bush will decide to handle this issue.
The Africa Policy Information Center (http://www.africapolicy.org) provided some background in an alert emailed on January 26:
"President Bush, after only three days in office, is reportedly considering reversing President Clinton's executive order preventing the U.S. from retaliating against African nations that seek to draw upon entirely legal provisions within the World Trade Organization to secure affordable medicines for the treatment of HIV/AIDS. The pharmaceutical industry, one of his largest corporate contributors, has aggressively sought to prevent African nations from using compulsory licensing and parallel imports to obtain these medicines cheaply..." [This alert is at http://www.africapolicy.org/adna/hiv010lc.htm]
Write or call President George W. Bush at the White House, Washington D.C. 20500, or 202-456-1111.
Write to your Senators at the U.S. Senate, Washington, D.C. 20501, and to your Congressional representative at the US. House of Representatives, Washington, D.C. 20515, or call their local or Washington offices. Make sure it is clear that you are a constituent.
* The AIDS crisis is one of the great disasters in history, and is worst in Africa;
* Brazil has achieved huge success in getting HIV treatment to those who need it, greatly reducing both AIDS deaths and new infections (see The New York Times Magazine, Sunday January 28, 2001, cover story, "How to Solve the World's AIDS Crisis," by Tina Rosenberg). The United States should not use its economic power to stop Brazil, or stop African countries from creating similar programs.
* The pharmaceutical-company plans for discounts or free drugs announced to date are unlikely to ever reach more than a tiny minority of Africans who need treatment.
* The current executive order will not reduce profits for future research and development, since all of Africa makes up less than 1.5% of the global pharmaceutical market. Only one in a thousand Africans with HIV are receiving modem treatment today, and the vast majority who are priced out of the market generate no profit or incentive for drug research and development.
|Printer friendly Cite/link Email Feedback|
|Author:||James, John S.|
|Publication:||AIDS Treatment News|
|Date:||Jan 26, 2001|
|Previous Article:||March 5: "Global Day of Action against Drug Company Profiteering," as Pharmaceutical Companies Sue South Africa to Block Low-Cost Medicines.|
|Next Article:||News Flash: Brazil; South Africa Lawsuit Letter.|